chr2-197572202-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144629.3(RFTN2):āc.1312T>Cā(p.Ser438Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,614,228 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144629.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFTN2 | NM_144629.3 | c.1312T>C | p.Ser438Pro | missense_variant | 9/9 | ENST00000295049.9 | NP_653230.2 | |
LOC124907952 | XR_007087918.1 | n.1327A>G | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFTN2 | ENST00000295049.9 | c.1312T>C | p.Ser438Pro | missense_variant | 9/9 | 1 | NM_144629.3 | ENSP00000295049 | P1 | |
RFTN2 | ENST00000454447.1 | c.388T>C | p.Ser130Pro | missense_variant | 5/5 | 3 | ENSP00000387459 | |||
RFTN2 | ENST00000494346.1 | n.484T>C | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000920 AC: 140AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251368Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135842
GnomAD4 exome AF: 0.0000451 AC: 66AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 727246
GnomAD4 genome AF: 0.000919 AC: 140AN: 152344Hom.: 0 Cov.: 33 AF XY: 0.000819 AC XY: 61AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2024 | The c.1312T>C (p.S438P) alteration is located in exon 9 (coding exon 9) of the RFTN2 gene. This alteration results from a T to C substitution at nucleotide position 1312, causing the serine (S) at amino acid position 438 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at